{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:54:23Z","timestamp":1790643263214,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T00:00:00Z","timestamp":1499817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"DEBRA Austria","award":["PI14\/00931"],"award-info":[{"award-number":["PI14\/00931"]}]},{"name":"DEBRA Austria","award":["SAF2013-43475-R"],"award-info":[{"award-number":["SAF2013-43475-R"]}]},{"name":"MINECO"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ymthe.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T18:01:23Z","timestamp":1499968883000},"page":"2573-2584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["COL7A1 Editing via CRISPR\/Cas9 in Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"25","author":[{"given":"Stefan","family":"Hainzl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Peking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Klausegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.07.005_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.15252\/emmm.201303374","article-title":"Targeted gene therapy and cell reprogramming in Fanconi anemia","volume":"6","author":"Rio","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2017.07.005_bib2","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for\u00a0correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2017.07.005_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.stem.2015.03.009","article-title":"Clinical translation of TALENS: treating SCID-X1 by gene editing in iPSCs","volume":"16","author":"Biffi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2017.07.005_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T\u00a0cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.07.005_bib5","doi-asserted-by":"crossref","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.07.005_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stemcr.2015.02.005","article-title":"Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells","volume":"4","author":"Crane","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.ymthe.2017.07.005_bib7","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2017.07.005_bib8","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.jid.2016.06.007","article-title":"Research techniques made simple: the application of CRISPR-Cas9 and genome editing in investigative dermatology","volume":"136","author":"Guitart","year":"2016","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib9","article-title":"Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders","author":"March","year":"2017","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib10","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.07.005_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib13","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1038\/mtna.2016.3","article-title":"A gene gun-mediated non-viral RNA trans-splicing strategy for Col7a1 repair","volume":"5","author":"Peking","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2017.07.005_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5582\/irdr.2017.01005","article-title":"Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Rashidghamat","year":"2017","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.ymthe.2017.07.005_bib15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex\u00a0vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib17","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1038\/mtna.2016.19","article-title":"gene editing for the efficient correction of a recurrent COL7A1 mutation in recessive dystrophic epidermolysis bullosa keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2017.07.005_bib18","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.ymthe.2017.07.005_bib19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.1614775114","article-title":"Efficient in\u00a0vivo gene editing using ribonucleoproteins in skin stem cells of\u00a0recessive dystrophic epidermolysis bullosa mouse model","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2017.07.005_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.07.005_bib21","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1093\/nar\/gkt076","article-title":"Mammalian base excision repair: the forgotten archangel","volume":"41","author":"Dianov","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.07.005_bib22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.07.005_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2350-11-139","article-title":"A prevalent mutation with founder effect in Spanish recessive dystrophic epidermolysis bullosa families","volume":"11","author":"Cuadrado-Corrales","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymthe.2017.07.005_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature13695","article-title":"Saturation\u00a0editing of genomic regions by multiplex homology-directed repair","volume":"513","author":"Findlay","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.07.005_bib25","doi-asserted-by":"crossref","first-page":"W401","DOI":"10.1093\/nar\/gku410","article-title":"CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing","volume":"42","author":"Montague","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.07.005_bib26","first-page":"1003","article-title":"Progress of application and off-target effects of CRISPR\/Cas9","volume":"37","author":"Wu","year":"2015","journal-title":"Yi Chuan"},{"key":"10.1016\/j.ymthe.2017.07.005_bib27","series-title":"Gene Therapy for Inherited Skin Disorders","author":"Lwin","year":"2017"},{"key":"10.1016\/j.ymthe.2017.07.005_bib28","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2017.07.005_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2017.07.005_bib30","doi-asserted-by":"crossref","first-page":"44061","DOI":"10.18632\/oncotarget.6392","article-title":"ASXL1 mutation correction by CRISPR\/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts","volume":"6","author":"Valletta","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2017.07.005_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2017.07.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.05.001","article-title":"Genome engineering in ophthalmology: application of CRISPR\/Cas to the treatment of eye disease","volume":"53","author":"Hung","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2017.07.005_bib33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.07.005_bib34","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib35","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13945","article-title":"A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa","volume":"173","author":"Schwieger-Briel","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.07.005_bib37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in\u00a0vivo","volume":"8","author":"Chen","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib39","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1128\/JVI.02757-13","article-title":"In\u00a0vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses","volume":"88","author":"Wang","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","article-title":"Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs","volume":"15","author":"Smith","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2017.07.005_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","article-title":"A rapid and general assay for monitoring endogenous gene modification","volume":"649","author":"Guschin","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/gt.2016.57","article-title":"Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations","volume":"23","author":"Tockner","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/10430340252939069","article-title":"A preclinical model for the analysis of genetically modified human skin in\u00a0vivo","volume":"13","author":"Del Rio","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.07.005_bib45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2353\/ajpath.2010.091096","article-title":"In\u00a0vivo assessment of acute UVB responses in normal and Xeroderma Pigmentosum (XP-C) skin-humanized mouse models","volume":"177","author":"Garc\u00eda","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2017.07.005_bib46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/jid.2010.353","article-title":"Development of skin-humanized mouse models of pachyonychia congenita","volume":"131","author":"Garc\u00eda","year":"2011","journal-title":"J.\u00a0Invest. Dermatol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:25:05Z","timestamp":1589768705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617303192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1525001617303192"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COL7A1 Editing via CRISPR\/Cas9 in Recessive Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}